Drug intelligence / Profile preview

aceclofenac + tramadol + acetaminophen

Development stage
Unknown
Lead developer
Almirall
Modality
Small Molecules
Administration
Oral
01

Overview

Aceclofenac + tramadol + acetaminophen is a fixed-dose combination medication used for the management of moderate to severe pain, particularly when pain is not adequately controlled by non-opioid analgesics alone. This oral formulation combines three active ingredients with complementary mechanisms: - **Aceclofenac** is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase (COX) enzymes, thereby reducing the synthesis of prostaglandins involved in inflammation and pain. - **Tramadol** is an opioid analgesic that acts centrally as a weak agonist at the mu-opioid receptor and also inhibits reuptake of norepinephrine and serotonin, contributing to its analgesic effects. - **Acetaminophen (paracetamol)** is an analgesic and antipyretic agent believed to act primarily through inhibition of central prostaglandin synthesis. The combination provides multimodal pain relief suitable for acute or chronic conditions such as musculoskeletal disorders or post-operative pain. It may be prescribed when monotherapy with NSAIDs or other non-opioids does not provide sufficient relief[3][4].

Other names
aceclofenac + paracetamol + tramadolaceclofenac + paracetamol/acetaminophen + tramadol
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)MOR (Mu opioid receptor)PGHS-1 (Prostaglandin G/H Synthase 1)SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)

Beyond the preview

Go deeper on aceclofenac + tramadol + acetaminophen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aceclofenac + tramadol + acetaminophen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call